Medline Inc. (NASDAQ: MDLN) Stock Competitors & Peer Comparison
See MDLN's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MDLN and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MDLN | $33.22 | -2.65% | 28.7B | 24.85 | $1.36 | N/A |
| ISRG | $392.80 | +0.41% | 140.5B | 41.34 | $9.62 | N/A |
| BDXA | $59.24 | -2.24% | 55.9B | 45.70 | $1.30 | +2.00% |
| BDX | $189.75 | +4.97% | 51.7B | 14.43 | $13.00 | +2.00% |
| WST | $360.24 | +3.94% | 24.8B | 44.29 | $7.97 | +0.25% |
| HOLX | $76.01 | +0.00% | 17B | 31.54 | $2.41 | N/A |
| SOLV | $88.79 | +1.53% | 15.2B | 12.37 | $7.10 | N/A |
| COO | $76.80 | +1.37% | 15B | 16.83 | $4.56 | N/A |
| BAX | $26.52 | +2.24% | 13.8B | 12.82 | $2.08 | +0.75% |
| BDXB | $48.16 | +1.39% | 13.7B | 7.60 | $6.33 | +2.00% |
Stock Comparison
Intuitive Surgical, Inc. (NASDAQ: ISRG)
MDLN vs ISRG Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, ISRG has a market cap of 140.5B. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while ISRG trades at $392.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas ISRG's P/E ratio is 41.34. In terms of profitability, MDLN's ROE is +0.05%, compared to ISRG's ROE of +0.18%. Regarding short-term risk, MDLN is more volatile compared to ISRG. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check ISRG's competition here
Becton, Dickinson and Company (NYSE: BDXA)
MDLN vs BDXA Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, BDXA has a market cap of 55.9B. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas BDXA's P/E ratio is 45.70. In terms of profitability, MDLN's ROE is +0.05%, compared to BDXA's ROE of +0.04%. Regarding short-term risk, MDLN is less volatile compared to BDXA. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check BDXA's competition here
Becton, Dickinson and Company (NYSE: BDX)
MDLN vs BDX Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, BDX has a market cap of 51.7B. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while BDX trades at $189.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas BDX's P/E ratio is 14.43. In terms of profitability, MDLN's ROE is +0.05%, compared to BDX's ROE of +0.04%. Regarding short-term risk, MDLN is more volatile compared to BDX. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check BDX's competition here
West Pharmaceutical Services, Inc. (NYSE: WST)
MDLN vs WST Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, WST has a market cap of 24.8B. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while WST trades at $360.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas WST's P/E ratio is 44.29. In terms of profitability, MDLN's ROE is +0.05%, compared to WST's ROE of +0.19%. Regarding short-term risk, MDLN is less volatile compared to WST. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check WST's competition here
Hologic, Inc. (NASDAQ: HOLX)
MDLN vs HOLX Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, HOLX has a market cap of 17B. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while HOLX trades at $76.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas HOLX's P/E ratio is 31.54. In terms of profitability, MDLN's ROE is +0.05%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, MDLN is more volatile compared to HOLX. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check HOLX's competition here
Solventum Corporation (NYSE: SOLV)
MDLN vs SOLV Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, SOLV has a market cap of 15.2B. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while SOLV trades at $88.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas SOLV's P/E ratio is 12.37. In terms of profitability, MDLN's ROE is +0.05%, compared to SOLV's ROE of +0.29%. Regarding short-term risk, MDLN is more volatile compared to SOLV. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check SOLV's competition here
The Cooper Companies, Inc. (NASDAQ: COO)
MDLN vs COO Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, COO has a market cap of 15B. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while COO trades at $76.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas COO's P/E ratio is 16.83. In terms of profitability, MDLN's ROE is +0.05%, compared to COO's ROE of +0.03%. Regarding short-term risk, MDLN is more volatile compared to COO. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check COO's competition here
Baxter International Inc. (NYSE: BAX)
MDLN vs BAX Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, BAX has a market cap of 13.8B. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while BAX trades at $26.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas BAX's P/E ratio is 12.82. In terms of profitability, MDLN's ROE is +0.05%, compared to BAX's ROE of -0.17%. Regarding short-term risk, MDLN is more volatile compared to BAX. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check BAX's competition here
Becton, Dickinson and Company (NYSE: BDXB)
MDLN vs BDXB Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas BDXB's P/E ratio is 7.60. In terms of profitability, MDLN's ROE is +0.05%, compared to BDXB's ROE of +0.04%. Regarding short-term risk, MDLN is more volatile compared to BDXB. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check BDXB's competition here
Repligen Corporation (NASDAQ: RGEN)
MDLN vs RGEN Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, RGEN has a market cap of 10B. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while RGEN trades at $185.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas RGEN's P/E ratio is 97.98. In terms of profitability, MDLN's ROE is +0.05%, compared to RGEN's ROE of +0.02%. Regarding short-term risk, MDLN is less volatile compared to RGEN. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check RGEN's competition here
Avantor, Inc. (NYSE: AVTR)
MDLN vs AVTR Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, AVTR has a market cap of 9.5B. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while AVTR trades at $14.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas AVTR's P/E ratio is 16.44. In terms of profitability, MDLN's ROE is +0.05%, compared to AVTR's ROE of -0.10%. Regarding short-term risk, MDLN is less volatile compared to AVTR. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check AVTR's competition here
AptarGroup, Inc. (NYSE: ATR)
MDLN vs ATR Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, ATR has a market cap of 8.5B. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while ATR trades at $133.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas ATR's P/E ratio is 23.24. In terms of profitability, MDLN's ROE is +0.05%, compared to ATR's ROE of +0.14%. Regarding short-term risk, MDLN is more volatile compared to ATR. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check ATR's competition here
Bausch + Lomb Corporation (NYSE: BLCO)
MDLN vs BLCO Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, BLCO has a market cap of 6.2B. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while BLCO trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas BLCO's P/E ratio is 26.85. In terms of profitability, MDLN's ROE is +0.05%, compared to BLCO's ROE of -0.03%. Regarding short-term risk, MDLN is more volatile compared to BLCO. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check BLCO's competition here
Teleflex Incorporated (NYSE: TFX)
MDLN vs TFX Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, TFX has a market cap of 6B. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while TFX trades at $136.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas TFX's P/E ratio is 15.54. In terms of profitability, MDLN's ROE is +0.05%, compared to TFX's ROE of -0.32%. Regarding short-term risk, MDLN is more volatile compared to TFX. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check TFX's competition here
Stevanato Group S.p.A. (NYSE: STVN)
MDLN vs STVN Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, STVN has a market cap of 5.9B. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while STVN trades at $22.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas STVN's P/E ratio is 32.92. In terms of profitability, MDLN's ROE is +0.05%, compared to STVN's ROE of +0.09%. Regarding short-term risk, MDLN is less volatile compared to STVN. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check STVN's competition here
Merit Medical Systems, Inc. (NASDAQ: MMSI)
MDLN vs MMSI Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, MMSI has a market cap of 5.5B. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while MMSI trades at $90.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas MMSI's P/E ratio is 23.52. In terms of profitability, MDLN's ROE is +0.05%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, MDLN is more volatile compared to MMSI. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check MMSI's competition here
ICU Medical, Inc. (NASDAQ: ICUI)
MDLN vs ICUI Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, ICUI has a market cap of 4.7B. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while ICUI trades at $187.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas ICUI's P/E ratio is 23.38. In terms of profitability, MDLN's ROE is +0.05%, compared to ICUI's ROE of +0.01%. Regarding short-term risk, MDLN is more volatile compared to ICUI. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check ICUI's competition here
Envista Holdings Corp (NYSE: NVST)
MDLN vs NVST Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, NVST has a market cap of 4.5B. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while NVST trades at $27.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas NVST's P/E ratio is 18.93. In terms of profitability, MDLN's ROE is +0.05%, compared to NVST's ROE of +0.04%. Regarding short-term risk, MDLN is more volatile compared to NVST. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check NVST's competition here
Pulse Biosciences, Inc. (NASDAQ: PLSE)
MDLN vs PLSE Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, PLSE has a market cap of 3.3B. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while PLSE trades at $48.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas PLSE's P/E ratio is -39.85. In terms of profitability, MDLN's ROE is +0.05%, compared to PLSE's ROE of -0.94%. Regarding short-term risk, MDLN is less volatile compared to PLSE. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check PLSE's competition here
AtriCure, Inc. (NASDAQ: ATRC)
MDLN vs ATRC Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, ATRC has a market cap of 2.4B. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while ATRC trades at $47.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas ATRC's P/E ratio is 1478.57. In terms of profitability, MDLN's ROE is +0.05%, compared to ATRC's ROE of +0.02%. Regarding short-term risk, MDLN is less volatile compared to ATRC. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check ATRC's competition here
DENTSPLY SIRONA Inc. (NASDAQ: XRAY)
MDLN vs XRAY Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, XRAY has a market cap of 2.2B. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while XRAY trades at $10.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas XRAY's P/E ratio is 7.71. In terms of profitability, MDLN's ROE is +0.05%, compared to XRAY's ROE of -0.40%. Regarding short-term risk, MDLN is less volatile compared to XRAY. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check XRAY's competition here
LeMaitre Vascular, Inc. (NASDAQ: LMAT)
MDLN vs LMAT Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, LMAT has a market cap of 1.9B. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while LMAT trades at $83.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas LMAT's P/E ratio is 30.83. In terms of profitability, MDLN's ROE is +0.05%, compared to LMAT's ROE of +0.16%. Regarding short-term risk, MDLN is more volatile compared to LMAT. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check LMAT's competition here
BioLife Solutions, Inc. (NASDAQ: BLFS)
MDLN vs BLFS Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, BLFS has a market cap of 1.8B. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while BLFS trades at $37.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas BLFS's P/E ratio is -172.56. In terms of profitability, MDLN's ROE is +0.05%, compared to BLFS's ROE of +0.13%. Regarding short-term risk, MDLN is less volatile compared to BLFS. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check BLFS's competition here
Azenta, Inc. (NASDAQ: AZTA)
MDLN vs AZTA Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, AZTA has a market cap of 1.6B. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while AZTA trades at $36.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas AZTA's P/E ratio is 84.81. In terms of profitability, MDLN's ROE is +0.05%, compared to AZTA's ROE of -0.08%. Regarding short-term risk, MDLN is less volatile compared to AZTA. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check AZTA's competition here
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS)
MDLN vs KMTS Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, KMTS has a market cap of 1.6B. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while KMTS trades at $27.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas KMTS's P/E ratio is -11.83. In terms of profitability, MDLN's ROE is +0.05%, compared to KMTS's ROE of -0.59%. Regarding short-term risk, MDLN is less volatile compared to KMTS. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check KMTS's competition here
STAAR Surgical Company (NASDAQ: STAA)
MDLN vs STAA Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, STAA has a market cap of 1.2B. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while STAA trades at $23.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas STAA's P/E ratio is 43.26. In terms of profitability, MDLN's ROE is +0.05%, compared to STAA's ROE of +0.01%. Regarding short-term risk, MDLN is less volatile compared to STAA. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check STAA's competition here
QuidelOrtho Corporation (NASDAQ: QDEL)
MDLN vs QDEL Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, QDEL has a market cap of 941M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while QDEL trades at $14.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas QDEL's P/E ratio is 10.30. In terms of profitability, MDLN's ROE is +0.05%, compared to QDEL's ROE of -0.55%. Regarding short-term risk, MDLN is less volatile compared to QDEL. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check QDEL's competition here
Atrion Corporation (NASDAQ: ATRI)
MDLN vs ATRI Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas ATRI's P/E ratio is 64.50. In terms of profitability, MDLN's ROE is +0.05%, compared to ATRI's ROE of +0.08%. Regarding short-term risk, MDLN is more volatile compared to ATRI. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check ATRI's competition here
AngioDynamics, Inc. (NASDAQ: ANGO)
MDLN vs ANGO Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, ANGO has a market cap of 664.2M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while ANGO trades at $16.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas ANGO's P/E ratio is -41.21. In terms of profitability, MDLN's ROE is +0.05%, compared to ANGO's ROE of -0.21%. Regarding short-term risk, MDLN is more volatile compared to ANGO. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check ANGO's competition here
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN)
MDLN vs NNNN Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, NNNN has a market cap of 366.5M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while NNNN trades at $7.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas NNNN's P/E ratio is 120.66. In terms of profitability, MDLN's ROE is +0.05%, compared to NNNN's ROE of +0.27%. Regarding short-term risk, MDLN is more volatile compared to NNNN. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check NNNN's competition here
Sanara MedTech Inc. (NASDAQ: SMTI)
MDLN vs SMTI Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, SMTI has a market cap of 315.1M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while SMTI trades at $34.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas SMTI's P/E ratio is -571.33. In terms of profitability, MDLN's ROE is +0.05%, compared to SMTI's ROE of -4.74%. Regarding short-term risk, MDLN is more volatile compared to SMTI. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check SMTI's competition here
OraSure Technologies, Inc. (NASDAQ: OSUR)
MDLN vs OSUR Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, OSUR has a market cap of 258.2M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while OSUR trades at $3.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas OSUR's P/E ratio is -6.82. In terms of profitability, MDLN's ROE is +0.05%, compared to OSUR's ROE of -0.15%. Regarding short-term risk, MDLN is more volatile compared to OSUR. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check OSUR's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
MDLN vs INFU Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, INFU has a market cap of 245.8M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while INFU trades at $12.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas INFU's P/E ratio is 29.71. In terms of profitability, MDLN's ROE is +0.05%, compared to INFU's ROE of +0.15%. Regarding short-term risk, MDLN is more volatile compared to INFU. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check INFU's competition here
Utah Medical Products, Inc. (NASDAQ: UTMD)
MDLN vs UTMD Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, UTMD has a market cap of 229.6M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while UTMD trades at $72.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas UTMD's P/E ratio is 21.34. In terms of profitability, MDLN's ROE is +0.05%, compared to UTMD's ROE of +0.09%. Regarding short-term risk, MDLN is more volatile compared to UTMD. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check UTMD's competition here
Pro-Dex, Inc. (NASDAQ: PDEX)
MDLN vs PDEX Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, PDEX has a market cap of 213.7M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while PDEX trades at $66.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas PDEX's P/E ratio is 23.57. In terms of profitability, MDLN's ROE is +0.05%, compared to PDEX's ROE of +0.29%. Regarding short-term risk, MDLN is more volatile compared to PDEX. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check PDEX's competition here
KORU Medical Systems, Inc. (NASDAQ: KRMD)
MDLN vs KRMD Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, KRMD has a market cap of 152.5M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while KRMD trades at $3.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas KRMD's P/E ratio is -83.00. In terms of profitability, MDLN's ROE is +0.05%, compared to KRMD's ROE of -0.11%. Regarding short-term risk, MDLN is more volatile compared to KRMD. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check KRMD's competition here
Microbot Medical Inc. (NASDAQ: MBOT)
MDLN vs MBOT Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, MBOT has a market cap of 70.6M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while MBOT trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas MBOT's P/E ratio is -5.96. In terms of profitability, MDLN's ROE is +0.05%, compared to MBOT's ROE of -0.22%. Regarding short-term risk, MDLN is less volatile compared to MBOT. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check MBOT's competition here
Akoya Biosciences, Inc. (NASDAQ: AKYA)
MDLN vs AKYA Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, AKYA has a market cap of 64.4M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while AKYA trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas AKYA's P/E ratio is -1.34. In terms of profitability, MDLN's ROE is +0.05%, compared to AKYA's ROE of -1.80%. Regarding short-term risk, MDLN is more volatile compared to AKYA. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check AKYA's competition here
Daxor Corporation (NASDAQ: DXR)
MDLN vs DXR Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, DXR has a market cap of 60.1M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while DXR trades at $10.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas DXR's P/E ratio is 5.67. In terms of profitability, MDLN's ROE is +0.05%, compared to DXR's ROE of +0.22%. Regarding short-term risk, MDLN is less volatile compared to DXR. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check DXR's competition here
SkyAI, Inc. (NASDAQ: STSS)
MDLN vs STSS Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, STSS has a market cap of 53.7M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while STSS trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas STSS's P/E ratio is -0.02. In terms of profitability, MDLN's ROE is +0.05%, compared to STSS's ROE of -1.54%. Regarding short-term risk, MDLN is less volatile compared to STSS. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check STSS's competition here
Nephros, Inc. (NASDAQ: NEPH)
MDLN vs NEPH Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, NEPH has a market cap of 51.7M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while NEPH trades at $4.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas NEPH's P/E ratio is 79.33. In terms of profitability, MDLN's ROE is +0.05%, compared to NEPH's ROE of +0.16%. Regarding short-term risk, MDLN is less volatile compared to NEPH. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check NEPH's competition here
Singular Genomics Systems, Inc. (NASDAQ: OMIC)
MDLN vs OMIC Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas OMIC's P/E ratio is -0.58. In terms of profitability, MDLN's ROE is +0.05%, compared to OMIC's ROE of -0.43%. Regarding short-term risk, MDLN is more volatile compared to OMIC. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check OMIC's competition here
GlucoTrack, Inc. (NASDAQ: IGAP)
MDLN vs IGAP Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas IGAP's P/E ratio is -10.52. In terms of profitability, MDLN's ROE is +0.05%, compared to IGAP's ROE of +1.80%. Regarding short-term risk, MDLN is more volatile compared to IGAP. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check IGAP's competition here
Precision Optics Corporation, Inc. (NASDAQ: POCI)
MDLN vs POCI Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, POCI has a market cap of 48.6M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while POCI trades at $4.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas POCI's P/E ratio is -6.17. In terms of profitability, MDLN's ROE is +0.05%, compared to POCI's ROE of -0.37%. Regarding short-term risk, MDLN is less volatile compared to POCI. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check POCI's competition here
Milestone Scientific Inc. (AMEX: MLSS)
MDLN vs MLSS Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, MLSS has a market cap of 42.4M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while MLSS trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas MLSS's P/E ratio is -7.99. In terms of profitability, MDLN's ROE is +0.05%, compared to MLSS's ROE of -1.49%. Regarding short-term risk, MDLN is more volatile compared to MLSS. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check MLSS's competition here
Harvard Bioscience, Inc. (NASDAQ: HBIO)
MDLN vs HBIO Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, HBIO has a market cap of 31.9M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while HBIO trades at $7.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas HBIO's P/E ratio is -19.67. In terms of profitability, MDLN's ROE is +0.05%, compared to HBIO's ROE of -0.92%. Regarding short-term risk, MDLN is less volatile compared to HBIO. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check HBIO's competition here
SmileDirectClub, Inc. (NASDAQ: SDC)
MDLN vs SDC Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas SDC's P/E ratio is -0.03. In terms of profitability, MDLN's ROE is +0.05%, compared to SDC's ROE of -1.96%. Regarding short-term risk, MDLN is less volatile compared to SDC. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check SDC's competition here
Invacare Corporation (NYSE: IVC)
MDLN vs IVC Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas IVC's P/E ratio is -0.79. In terms of profitability, MDLN's ROE is +0.05%, compared to IVC's ROE of -0.46%. Regarding short-term risk, MDLN is less volatile compared to IVC. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check IVC's competition here
Jin Medical International Ltd. (NASDAQ: ZJYL)
MDLN vs ZJYL Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, ZJYL has a market cap of 24.1M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while ZJYL trades at $3.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas ZJYL's P/E ratio is 19.25. In terms of profitability, MDLN's ROE is +0.05%, compared to ZJYL's ROE of +0.04%. Regarding short-term risk, MDLN is less volatile compared to ZJYL. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check ZJYL's competition here
Retractable Technologies, Inc. (AMEX: RVP)
MDLN vs RVP Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, RVP has a market cap of 21.7M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while RVP trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas RVP's P/E ratio is -2.20. In terms of profitability, MDLN's ROE is +0.05%, compared to RVP's ROE of -0.05%. Regarding short-term risk, MDLN is more volatile compared to RVP. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check RVP's competition here
Regentis Biomaterials Ltd. (AMEX: RGNT)
MDLN vs RGNT Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, RGNT has a market cap of 15.6M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while RGNT trades at $2.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas RGNT's P/E ratio is -0.09. In terms of profitability, MDLN's ROE is +0.05%, compared to RGNT's ROE of N/A. Regarding short-term risk, MDLN is less volatile compared to RGNT. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check RGNT's competition here
Femasys Inc. (NASDAQ: FEMY)
MDLN vs FEMY Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, FEMY has a market cap of 7.9M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while FEMY trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas FEMY's P/E ratio is -7.21. In terms of profitability, MDLN's ROE is +0.05%, compared to FEMY's ROE of -2.26%. Regarding short-term risk, MDLN is less volatile compared to FEMY. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check FEMY's competition here
NanoString Technologies, Inc. (NASDAQ: NSTG)
MDLN vs NSTG Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas NSTG's P/E ratio is -0.03. In terms of profitability, MDLN's ROE is +0.05%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, MDLN is less volatile compared to NSTG. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check NSTG's competition here
Lucyd, Inc (NASDAQ: LUCY)
MDLN vs LUCY Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, LUCY has a market cap of 4.4M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while LUCY trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas LUCY's P/E ratio is -0.41. In terms of profitability, MDLN's ROE is +0.05%, compared to LUCY's ROE of -0.89%. Regarding short-term risk, MDLN is less volatile compared to LUCY. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check LUCY's competition here
Predictive Oncology Inc. (NASDAQ: POAI)
MDLN vs POAI Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, POAI has a market cap of 3.6M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while POAI trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas POAI's P/E ratio is -0.03. In terms of profitability, MDLN's ROE is +0.05%, compared to POAI's ROE of -21.19%. Regarding short-term risk, MDLN is less volatile compared to POAI. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check POAI's competition here
NEXGEL, Inc. (NASDAQ: NXGL)
MDLN vs NXGL Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, NXGL has a market cap of 3.3M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while NXGL trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas NXGL's P/E ratio is -0.55. In terms of profitability, MDLN's ROE is +0.05%, compared to NXGL's ROE of -1.33%. Regarding short-term risk, MDLN is less volatile compared to NXGL. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check NXGL's competition here
GlucoTrack, Inc. (NASDAQ: GCTK)
MDLN vs GCTK Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, GCTK has a market cap of 2.7M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while GCTK trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas GCTK's P/E ratio is -0.02. In terms of profitability, MDLN's ROE is +0.05%, compared to GCTK's ROE of -21.36%. Regarding short-term risk, MDLN is less volatile compared to GCTK. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check GCTK's competition here
Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA)
MDLN vs MHUA Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, MHUA has a market cap of 2.4M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while MHUA trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas MHUA's P/E ratio is 0.25. In terms of profitability, MDLN's ROE is +0.05%, compared to MHUA's ROE of +0.07%. Regarding short-term risk, MDLN is more volatile compared to MHUA. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check MHUA's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVD)
MDLN vs GMVD Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas GMVD's P/E ratio is -0.01. In terms of profitability, MDLN's ROE is +0.05%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, MDLN is less volatile compared to GMVD. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check GMVD's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVDW)
MDLN vs GMVDW Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas GMVDW's P/E ratio is N/A. In terms of profitability, MDLN's ROE is +0.05%, compared to GMVDW's ROE of +2.09%. Regarding short-term risk, MDLN is less volatile compared to GMVDW. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check GMVDW's competition here
NEXGEL, Inc. (NASDAQ: NXGLW)
MDLN vs NXGLW Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, NXGLW has a market cap of 1.5M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while NXGLW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas NXGLW's P/E ratio is -0.05. In terms of profitability, MDLN's ROE is +0.05%, compared to NXGLW's ROE of -1.33%. Regarding short-term risk, MDLN is more volatile compared to NXGLW. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check NXGLW's competition here
Avinger, Inc. (NASDAQ: AVGR)
MDLN vs AVGR Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas AVGR's P/E ratio is -0.05. In terms of profitability, MDLN's ROE is +0.05%, compared to AVGR's ROE of +17.82%. Regarding short-term risk, MDLN is less volatile compared to AVGR. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check AVGR's competition here
Lucyd, Inc (NASDAQ: LUCYW)
MDLN vs LUCYW Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, LUCYW has a market cap of 296.1K. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas LUCYW's P/E ratio is N/A. In terms of profitability, MDLN's ROE is +0.05%, compared to LUCYW's ROE of -0.89%. Regarding short-term risk, MDLN is less volatile compared to LUCYW. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check LUCYW's competition here
Apria, Inc. (NASDAQ: APR)
MDLN vs APR Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, APR has a market cap of 0. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas APR's P/E ratio is 22.59. In terms of profitability, MDLN's ROE is +0.05%, compared to APR's ROE of +9.81%. Regarding short-term risk, MDLN is more volatile compared to APR. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check APR's competition here
Hill-Rom Holdings, Inc. (NYSE: HRC)
MDLN vs HRC Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, HRC has a market cap of 0. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas HRC's P/E ratio is 41.92. In terms of profitability, MDLN's ROE is +0.05%, compared to HRC's ROE of +0.14%. Regarding short-term risk, MDLN is more volatile compared to HRC. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check HRC's competition here
IntriCon Corporation (NASDAQ: IIN)
MDLN vs IIN Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, IIN has a market cap of 0. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas IIN's P/E ratio is 226.45. In terms of profitability, MDLN's ROE is +0.05%, compared to IIN's ROE of -0.00%. Regarding short-term risk, MDLN is more volatile compared to IIN. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check IIN's competition here
Analogic Corporation (NASDAQ: ALOG)
MDLN vs ALOG Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, ALOG has a market cap of 0. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while ALOG trades at $83.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas ALOG's P/E ratio is 40.93. In terms of profitability, MDLN's ROE is +0.05%, compared to ALOG's ROE of -0.15%. Regarding short-term risk, MDLN is more volatile compared to ALOG. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check ALOG's competition here
Invuity, Inc. (NASDAQ: IVTY)
MDLN vs IVTY Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, IVTY has a market cap of 0. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while IVTY trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas IVTY's P/E ratio is -3.80. In terms of profitability, MDLN's ROE is +0.05%, compared to IVTY's ROE of -2.40%. Regarding short-term risk, MDLN is more volatile compared to IVTY. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check IVTY's competition here
Antares Pharma, Inc. (NASDAQ: ATRS)
MDLN vs ATRS Comparison August 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 28.7B. In comparison, ATRS has a market cap of 0. Regarding current trading prices, MDLN is priced at $33.22 on the NASDAQ, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 24.85, whereas ATRS's P/E ratio is 14.95. In terms of profitability, MDLN's ROE is +0.05%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, MDLN is more volatile compared to ATRS. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check ATRS's competition here